课题基金 / 基金详情

Development of Iron Chelators for the Treatment of Friedreichs Ataxia and the Role of Frataxin in Iron Metabolism

Development of Iron Chelators for the Treatment of Friedreichs Ataxia and the Role of Frataxin in Iron Metabolism
治疗弗里德赖希共济失调的铁螯合剂的开发以及 Frataxin 在铁代谢中的作用
批准号:
nhmrc : 512377
负责人:
Prof Des Richardson
金额:
$36.74万
依托单位:
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2008
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2008-01-01 至 2010-12-31

项目摘要

项目成果

Prof Des Richardson的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Friedreich's ataxia (FA) is a neuro- and cardio-degenerative disease where there is an accumulation of toxic Fe in the mitochondrion. Excitingly, work from our current NHMRC grant showed iron plays a significant role in FA pathology. Importantly, we developed new drugs (Fe chelators) which rescue the cardiac pathology of FA in an animal model. Studies will now assess if our drugs prevent the neurodegeneration of FA in another animal model. This work could lead to novel therapies for FA.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The “New” Biochemistry of Polyamines: When Metabolic Pathways Collide
  • 批准号:
    DP200103530
  • 项目类别:
    Discovery Projects
  • 资助金额:
    $30.74万
  • 财政年份:
    2020
  • 负责人:
    Prof Des Richardson
  • 依托单位:
Pharmacological and Pharmaceutical Development of Novel Drugs for Multiple Major Disease States
  • 批准号:
    nhmrc : GNT1159596
  • 项目类别:
    Research Fellowships
  • 资助金额:
    $88.83万
  • 财政年份:
    2019
  • 负责人:
    Prof Des Richardson
  • 依托单位:
Biomedical Investigations of Pharmacology and Pathology for Disease Treatment
  • 批准号:
    nhmrc : 1062607
  • 项目类别:
    Research Fellowships
  • 资助金额:
    $57.57万
  • 财政年份:
    2014
  • 负责人:
    Prof Des Richardson
  • 依托单位:
Biomedical Investigations of Pharmacology and Pathology
  • 批准号:
    nhmrc : GNT1062607
  • 项目类别:
    Research Fellowships
  • 资助金额:
    $82.29万
  • 财政年份:
    2014
  • 负责人:
    Prof Des Richardson
  • 依托单位:
国内基金
海外基金
Iron/STAT3轴介导CD71+中性粒细胞释放NETs诱导宫颈癌发生免疫逃逸的机制研究
  • 批准号:
    2026JJ81334
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    冯也倩
  • 依托单位:
IRON MAN正调控铁信号核心转录因子FIT的分子机制